Literature DB >> 12652530

In vivo measurement of brain metabolites using two-dimensional double-quantum MR spectroscopy--exploration of GABA levels in a ketogenic diet.

Zhiyue J Wang1, Christina Bergqvist, Jill V Hunter, Dongzhu Jin, Dah-Jyuu Wang, Suzanne Wehrli, Robert A Zimmerman.   

Abstract

A localized proton 2D double-quantum (DQ) spin-echo spectroscopy technique was implemented on 1.5 T clinical MRI scanners for the detection of gamma-aminobutyrate (GABA) in the brain. The 2D approach facilitates separation of peaks overlapping with GABA in 1D DQ-filtered (DQF) spectra. This technique was applied to four normal adult volunteers and four children with intractable epilepsy. The coefficient of variation of the level of GABA and overlapping macromolecules at F2 = 3.0 ppm and F1 = 4.8 ppm was 0.08 in normal subjects. Three patients received 2D MRS scans before and after initiation of the ketogenic diet (KD): one patient showed a trend of decreasing GABA throughout the study, and two patients showed low initial GABA levels that increased over time. In addition to major metabolites and GABA, low-level metabolites (valine, leucine, and glutathione) were also identified in the 2D spectra. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652530     DOI: 10.1002/mrm.10429

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  25 in total

Review 1.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

Review 2.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

Review 3.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

4.  The ketogenic diet increases Neuregulin 1 expression via elevating histone acetylation and its anti-seizure effect requires ErbB4 kinase activity.

Authors:  Jin Wang; Jie Huang; Shan Yao; Jia-Hui Wu; Hui-Bin Li; Feng Gao; Ying Wang; Guo-Bin Huang; Qiang-Long You; Jianhua Li; Xiaohui Chen; Xiang-Dong Sun
Journal:  Cell Biosci       Date:  2021-05-21       Impact factor: 7.133

5.  Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.

Authors:  In-Young Choi; Phil Lee
Journal:  NMR Biomed       Date:  2012-06-22       Impact factor: 4.044

Review 6.  Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?

Authors:  Timothy A Simeone; Kristina A Simeone; Carl E Stafstrom; Jong M Rho
Journal:  Neuropharmacology       Date:  2018-01-08       Impact factor: 5.250

7.  Protective effect of the ketogenic diet in Scn1a mutant mice.

Authors:  Stacey B B Dutton; Nikki T Sawyer; Franck Kalume; Patricia Jumbo-Lucioni; Karin Borges; William A Catterall; Andrew Escayg
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

8.  Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats.

Authors:  Madeline E Rhodes; Jayanth Talluri; Jacob P Harney; Cheryl A Frye
Journal:  Epilepsy Behav       Date:  2005-09       Impact factor: 2.937

9.  BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures.

Authors:  Alfredo Giménez-Cassina; Juan Ramón Martínez-François; Jill K Fisher; Benjamin Szlyk; Klaudia Polak; Jessica Wiwczar; Geoffrey R Tanner; Andrew Lutas; Gary Yellen; Nika N Danial
Journal:  Neuron       Date:  2012-05-24       Impact factor: 17.173

Review 10.  The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect.

Authors:  Marc Yudkoff; Yevgeny Daikhin; Torun Margareta Melø; Ilana Nissim; Ursula Sonnewald; Itzhak Nissim
Journal:  Annu Rev Nutr       Date:  2007       Impact factor: 11.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.